Proscia And Nucleai Partner To Broaden Access To AI Predictive Biomarkers

Expanding Proscia’s precision medicine AI pipeline will help to optimize clinical trials and improve treatment decisions

Argonaut Partner to Offer Accelerated End-to-End Drug Development Support for Biopharmaceutical Companies

Biopharma gains a seamless transition from drug discovery through drug product manufacturing

ResultsCX Wins Two 2024 Fortress Cybersecurity Awards

Aranscia and Signature RX Announce Personalized Medication Management Program for GLP-1s

Bora Pharmaceuticals Expands North American Footprint with Agreement to Acquire First Sterile Manufacturing Facility

Clinion and Clinevo’s Strategic Alliance for An Integrated eClinical Experience

AI-powered eClinical Platform, Clinion, announces strategic partnership with eClinical safety solutions provider, Clinevo.

ZeOmega Launches HealthFeed SMS Texting for Enhanced Member Engagement

TP-ACO Selects YouScript for Personalized Medication Management Initiative

Cresset Successfully Achieves SOC 2 Compliance

AKASA Unveils AKASA Medical CodingTM for Enhanced Revenue Cycle Management with Generative AI

Instem And Proscia Partner To Accelerate Preclinical Development With Digital Pathology

Instem, a leading provider of IT solutions and services to the global life sciences market, has partnered with Proscia®, a global leader in AI-enhanced pathology solutions for precision medicine.

CluePoints Continues ‘Turning Artificial Intelligence into Human Intelligence’ by Launching Two New Innovations

CluePoints Continues ‘Turning Artificial Intelligence into Human Intelligence’ by Launching Two New Innovations Site Profile & Oversight Tool (SPOT) and Intelligent Medical Coding (IMC) unveiled by RBQM innovator at DIA Global Annual Meeting 2024

Huateng Pharma to Exhibit at CPHI China 2024

ProPharma Honored with 2024 CRO Leadership Award

ProPharma, the world’s largest research consulting organization (RCO), a leading global provider of regulatory, clinical, and compliance services for the life sciences industry is pleased to announce it received a 2024 CRO Leadership Award.

Uppsala University Hospital chooses AI-based Qlucore Insights to develop precision diagnostics

Please see latest news from Qlucore who has signed an agreement with Uppsala University Hospital. The Hospital will use the Qlucore Insights software to improve the analysis of acute lymphoblastic leukemia (ALL) in children. Please get in touch if you require further information.

New Research Illustrates How to Drive Earlier Diagnosis and Treatment of Kidney Disease

A new survey by Phreesia, in partnership with the National Kidney Foundation, finds that discussions between patients and providers, and patient activation, are key to helping high-risk patients take preventive actions to manage their kidney health.

Onyx Scientific Aims for European Growth with New BD Hire

Small molecule specialists Onyx Scientific has made a significant new addition to its commercial team with the appointment of Courtnie Thomas Wilks as Business Development Manager for the UK and Europe.

MIB Agents’ Community of Families Has Awarded Over $1.9M in Grants to Research Pediatric Bone Cancer

Mage Biologics announces first subject dosed in a Phase 1 trial with MB-001, an orally administered antibody for Inflammatory Bowel Disease

Mage Biologics (“Mage”) announces it has dosed the first study participant in a first-in-human study of MB-001, a best-in-class orally administered antibody designed for the treatment of inflammatory bowel disease (IBD).

Integrated DNA Technologies Announces New Primers and Probe Set to Identify H5N1 Avian Influenza

Integrated DNA Technologies today launched the Avian Influenza Type A (H5) Primers and Probe Set to enable researchers to identify, target, and trace the presence of clade 2.3.4.4b of the H5N1 virus across bird, environmental, dairy cow, and poultry farm samples.